Baird Financial Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-69,032
| Closed | -$755K | – | 1379 |
|
|
2018
Q3 | $755K | Sell |
69,032
-2,188
| -3% | -$23.9K | ﹤0.01% | 924 |
|
|
2018
Q2 | $956K | Buy |
71,220
+728
| +1% | +$9.77K | 0.01% | 840 |
|
|
2018
Q1 | $916K | Sell |
70,492
-36,957
| -34% | -$480K | 0.01% | 848 |
|
|
2017
Q4 | $989K | Buy |
107,449
+22,712
| +27% | +$209K | 0.01% | 827 |
|
|
2017
Q3 | $683K | Buy |
+84,737
| New | +$683K | 0.01% | 905 |
|